Balance Sheet
Accounts PayablesAccumulated ExpensesCash & Current InvestmentsCash & EquivalentsCurrent AssetsCurrent TaxesGoodwill & IntangiblesInventoryLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zhengye Biotechnology Holding (ZYBT) Assets: 2023-2024

  • Zhengye Biotechnology Holding's Assets fell 2.67% to $67.6 million in Q4 2024 from the same period last year, while for Dec 2024 it was $67.6 million, marking a year-over-year decrease of 2.67%. This contributed to the annual value of $68.6 million for FY2024, which is 2.95% down from last year.
  • As of Q4 2024, Zhengye Biotechnology Holding's Assets stood at $67.6 million, which was down 2.67% from $69.4 million recorded in Q4 2023.
  • Zhengye Biotechnology Holding's 5-year Assets high stood at $69.4 million for Q4 2023, and its period low was $67.6 million during Q4 2024.
  • For the 2-year period, Zhengye Biotechnology Holding's Assets averaged around $68.5 million, with its median value being $68.5 million (2023).
  • Data for Zhengye Biotechnology Holding's Assets shows a maximum YoY decreased of 2.67% (in 2024) over the last 5 years.
  • Zhengye Biotechnology Holding's Assets (Quarterly) stood at $69.4 million in 2023, then dropped by 2.67% to $67.6 million in 2024.